

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of oxidative stress-induced neuron death (GO:1903203) | 5.79314240 |
| 2 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.65181530 |
| 3 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.57373715 |
| 4 | response to muscle activity (GO:0014850) | 4.41895633 |
| 5 | paraxial mesoderm development (GO:0048339) | 4.27074054 |
| 6 | regulation of autophagic vacuole assembly (GO:2000785) | 4.22616592 |
| 7 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 4.15880846 |
| 8 | positive regulation of catecholamine secretion (GO:0033605) | 4.11438830 |
| 9 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.02282597 |
| 10 | regulation of vacuole organization (GO:0044088) | 3.80453933 |
| 11 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.76867908 |
| 12 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.69123399 |
| 13 | TOR signaling (GO:0031929) | 3.54870351 |
| 14 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.51919608 |
| 15 | protein localization to cell surface (GO:0034394) | 3.50664156 |
| 16 | pre-miRNA processing (GO:0031054) | 3.50121249 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.46907559 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.38569377 |
| 19 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.36931936 |
| 20 | coenzyme catabolic process (GO:0009109) | 3.34245759 |
| 21 | myofibril assembly (GO:0030239) | 3.32485291 |
| 22 | mRNA cleavage (GO:0006379) | 3.24377896 |
| 23 | protein complex localization (GO:0031503) | 3.22339621 |
| 24 | histone demethylation (GO:0016577) | 3.19722314 |
| 25 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.15633244 |
| 26 | cGMP-mediated signaling (GO:0019934) | 3.12661882 |
| 27 | lysine metabolic process (GO:0006553) | 3.11623154 |
| 28 | lysine catabolic process (GO:0006554) | 3.11623154 |
| 29 | cellular response to osmotic stress (GO:0071470) | 3.07446320 |
| 30 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.06207732 |
| 31 | nuclear pore complex assembly (GO:0051292) | 3.03754460 |
| 32 | muscle cell cellular homeostasis (GO:0046716) | 3.01394448 |
| 33 | receptor recycling (GO:0001881) | 2.99270843 |
| 34 | glycogen metabolic process (GO:0005977) | 2.98679777 |
| 35 | cellular glucan metabolic process (GO:0006073) | 2.98290907 |
| 36 | glucan metabolic process (GO:0044042) | 2.98290907 |
| 37 | actin-mediated cell contraction (GO:0070252) | 2.97841728 |
| 38 | growth hormone receptor signaling pathway (GO:0060396) | 2.93725322 |
| 39 | muscle filament sliding (GO:0030049) | 2.93137880 |
| 40 | actin-myosin filament sliding (GO:0033275) | 2.93137880 |
| 41 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.88752290 |
| 42 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.82501663 |
| 43 | homocysteine metabolic process (GO:0050667) | 2.82178543 |
| 44 | regulation of myoblast differentiation (GO:0045661) | 2.82164903 |
| 45 | actin filament-based movement (GO:0030048) | 2.81680085 |
| 46 | phospholipid homeostasis (GO:0055091) | 2.81609003 |
| 47 | urea cycle (GO:0000050) | 2.80577726 |
| 48 | urea metabolic process (GO:0019627) | 2.80577726 |
| 49 | AMP metabolic process (GO:0046033) | 2.79934000 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.79624496 |
| 51 | L-phenylalanine catabolic process (GO:0006559) | 2.79624496 |
| 52 | activation of protein kinase B activity (GO:0032148) | 2.79046062 |
| 53 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.78737547 |
| 54 | cysteine metabolic process (GO:0006534) | 2.78477022 |
| 55 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.78176281 |
| 56 | protein dealkylation (GO:0008214) | 2.76752864 |
| 57 | protein demethylation (GO:0006482) | 2.76752864 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 2.74380046 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 2.74203285 |
| 60 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.74014182 |
| 61 | hippo signaling (GO:0035329) | 2.73620918 |
| 62 | cell adhesion mediated by integrin (GO:0033627) | 2.73291620 |
| 63 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.73219001 |
| 64 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.72499314 |
| 65 | radial glial cell differentiation (GO:0060019) | 2.70216626 |
| 66 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.69119599 |
| 67 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.68515772 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.67750548 |
| 69 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.67561306 |
| 70 | COPII vesicle coating (GO:0048208) | 2.66899616 |
| 71 | mitotic sister chromatid cohesion (GO:0007064) | 2.66859925 |
| 72 | nuclear pore organization (GO:0006999) | 2.65686246 |
| 73 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.65605717 |
| 74 | cardiac muscle hypertrophy (GO:0003300) | 2.65388828 |
| 75 | cell-substrate adherens junction assembly (GO:0007045) | 2.65217072 |
| 76 | focal adhesion assembly (GO:0048041) | 2.65217072 |
| 77 | negative regulation of defense response to virus (GO:0050687) | 2.64977734 |
| 78 | sarcomere organization (GO:0045214) | 2.64071632 |
| 79 | heterochromatin organization (GO:0070828) | 2.62799704 |
| 80 | complement activation, alternative pathway (GO:0006957) | 2.62632057 |
| 81 | histone H3-K9 demethylation (GO:0033169) | 2.61975120 |
| 82 | kynurenine metabolic process (GO:0070189) | 2.61446307 |
| 83 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.59305313 |
| 84 | bile acid biosynthetic process (GO:0006699) | 2.58344955 |
| 85 | ADP metabolic process (GO:0046031) | 2.58226078 |
| 86 | midgut development (GO:0007494) | 2.57824369 |
| 87 | ribosome assembly (GO:0042255) | 2.57546299 |
| 88 | chondrocyte development (GO:0002063) | 2.57002242 |
| 89 | regulation of phospholipase A2 activity (GO:0032429) | 2.56852810 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.56565144 |
| 91 | L-phenylalanine metabolic process (GO:0006558) | 2.56565144 |
| 92 | positive regulation of fatty acid oxidation (GO:0046321) | 2.56436098 |
| 93 | fibroblast migration (GO:0010761) | 2.56391416 |
| 94 | cellular response to arsenic-containing substance (GO:0071243) | 2.55740827 |
| 95 | N-terminal protein amino acid acetylation (GO:0006474) | 2.55205156 |
| 96 | aromatic amino acid family catabolic process (GO:0009074) | 2.55020492 |
| 97 | positive regulation of histone deacetylation (GO:0031065) | 2.55010338 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 2.54846437 |
| 99 | regulation of protein activation cascade (GO:2000257) | 2.54580398 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.53256981 |
| 101 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.52392216 |
| 102 | membrane budding (GO:0006900) | 2.52120180 |
| 103 | mRNA stabilization (GO:0048255) | 2.52044170 |
| 104 | RNA stabilization (GO:0043489) | 2.52044170 |
| 105 | relaxation of smooth muscle (GO:0044557) | 2.50854236 |
| 106 | adherens junction assembly (GO:0034333) | 2.49903776 |
| 107 | iron ion import (GO:0097286) | 2.49000481 |
| 108 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.48764681 |
| 109 | protein carboxylation (GO:0018214) | 2.48764681 |
| 110 | apoptotic cell clearance (GO:0043277) | 2.48422494 |
| 111 | cellular response to growth hormone stimulus (GO:0071378) | 2.46508528 |
| 112 | corticosteroid receptor signaling pathway (GO:0031958) | 2.46383276 |
| 113 | protein localization to endosome (GO:0036010) | 2.46245209 |
| 114 | COPI coating of Golgi vesicle (GO:0048205) | 2.45962020 |
| 115 | Golgi transport vesicle coating (GO:0048200) | 2.45962020 |
| 116 | striated muscle hypertrophy (GO:0014897) | 2.45422008 |
| 117 | protein-lipid complex assembly (GO:0065005) | 2.44852445 |
| 118 | positive regulation of p38MAPK cascade (GO:1900745) | 2.44730477 |
| 119 | NLS-bearing protein import into nucleus (GO:0006607) | 2.43848818 |
| 120 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.43663962 |
| 121 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.43548533 |
| 122 | pore complex assembly (GO:0046931) | 2.43473851 |
| 123 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.43211446 |
| 124 | regulation of complement activation (GO:0030449) | 2.40915836 |
| 125 | epoxygenase P450 pathway (GO:0019373) | 2.40627867 |
| 126 | endoplasmic reticulum organization (GO:0007029) | 2.40570329 |
| 127 | cellular response to lithium ion (GO:0071285) | 2.40450195 |
| 128 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.40320346 |
| 129 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.40111010 |
| 130 | sulfur amino acid catabolic process (GO:0000098) | 2.39749456 |
| 131 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.39503752 |
| 132 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.39494204 |
| 133 | Leydig cell differentiation (GO:0033327) | 2.37256427 |
| 134 | plasma lipoprotein particle clearance (GO:0034381) | 2.36836787 |
| 135 | lipoprotein metabolic process (GO:0042157) | 2.36478778 |
| 136 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.35516286 |
| 137 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.35496144 |
| 138 | negative regulation of JNK cascade (GO:0046329) | 2.35285249 |
| 139 | fatty acid transmembrane transport (GO:1902001) | 2.35139820 |
| 140 | peptidyl-threonine modification (GO:0018210) | 2.35095491 |
| 141 | low-density lipoprotein particle clearance (GO:0034383) | 2.34908076 |
| 142 | plasma lipoprotein particle assembly (GO:0034377) | 2.34544467 |
| 143 | embryonic process involved in female pregnancy (GO:0060136) | 2.33968757 |
| 144 | cortical actin cytoskeleton organization (GO:0030866) | 2.33464062 |
| 145 | nitrogen cycle metabolic process (GO:0071941) | 2.33395465 |
| 146 | negative regulation of fatty acid transport (GO:2000192) | 2.32357364 |
| 147 | tryptophan metabolic process (GO:0006568) | 2.32215101 |
| 148 | regulation of RNA export from nucleus (GO:0046831) | 2.30782458 |
| 149 | regulation of skeletal muscle fiber development (GO:0048742) | 2.30533170 |
| 150 | energy homeostasis (GO:0097009) | 2.30404221 |
| 151 | regulation of fibroblast apoptotic process (GO:2000269) | 2.30183846 |
| 152 | regulation of DNA-templated transcription, initiation (GO:2000142) | 2.30126287 |
| 153 | regulation of fibrinolysis (GO:0051917) | 2.28908509 |
| 154 | negative regulation of lipid transport (GO:0032369) | 2.28765500 |
| 155 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.28757079 |
| 156 | cellular polysaccharide metabolic process (GO:0044264) | 2.28208958 |
| 157 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.28171041 |
| 158 | muscle hypertrophy in response to stress (GO:0003299) | 2.28171041 |
| 159 | cardiac muscle adaptation (GO:0014887) | 2.28171041 |
| 160 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.27090922 |
| 161 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.26839213 |
| 162 | positive regulation of glycolytic process (GO:0045821) | 2.26784421 |
| 163 | 2-oxoglutarate metabolic process (GO:0006103) | 2.26745783 |
| 164 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.26564624 |
| 165 | positive regulation of myoblast differentiation (GO:0045663) | 2.26293236 |
| 166 | negative regulation of sterol transport (GO:0032372) | 2.26290889 |
| 167 | negative regulation of cholesterol transport (GO:0032375) | 2.26290889 |
| 168 | glyoxylate metabolic process (GO:0046487) | 2.26116970 |
| 169 | carnitine shuttle (GO:0006853) | 2.26085256 |
| 170 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.25949901 |
| 171 | histone lysine demethylation (GO:0070076) | 2.25734094 |
| 172 | tryptophan catabolic process (GO:0006569) | 2.25721728 |
| 173 | indole-containing compound catabolic process (GO:0042436) | 2.25721728 |
| 174 | indolalkylamine catabolic process (GO:0046218) | 2.25721728 |
| 175 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.25162816 |
| 176 | urate metabolic process (GO:0046415) | 2.25126010 |
| 177 | regulation of sister chromatid cohesion (GO:0007063) | 2.25063108 |
| 178 | regulation of cholesterol storage (GO:0010885) | 2.24776430 |
| 179 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.23459446 |
| 180 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.22216851 |
| 181 | negative regulation of heart growth (GO:0061117) | 2.21614641 |
| 182 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.21614641 |
| 183 | macroautophagy (GO:0016236) | 2.21428046 |
| 184 | regulation of triglyceride catabolic process (GO:0010896) | 2.20928516 |
| 185 | valine metabolic process (GO:0006573) | 2.20891957 |
| 186 | polarized epithelial cell differentiation (GO:0030859) | 2.19419327 |
| 187 | reverse cholesterol transport (GO:0043691) | 2.18811082 |
| 188 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.18243007 |
| 189 | bile acid metabolic process (GO:0008206) | 2.17533951 |
| 190 | histone H3-K36 demethylation (GO:0070544) | 2.16910003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.65645192 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.27508419 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.12131194 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.26205616 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.20459094 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19395745 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17257726 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.12020788 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99980789 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.79354600 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.76762550 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.69366538 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.61741517 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.55188358 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.26861895 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.18025019 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17121838 |
| 18 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.12590891 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.02197812 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.98147485 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93792403 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91460481 |
| 23 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.81980286 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77790442 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77193231 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76627338 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75736453 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75042362 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73009255 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69859030 |
| 31 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.66930326 |
| 32 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.65221756 |
| 33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62868240 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.58293494 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58123035 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56840150 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55960139 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53539800 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53239405 |
| 40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.52723692 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.50946269 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50750881 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50482951 |
| 44 | RXR_22108803_ChIP-Seq_LS180_Human | 1.48828495 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47176683 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46886316 |
| 47 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46783015 |
| 48 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.46234390 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45758614 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45537689 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44626259 |
| 52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.44280113 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42867646 |
| 54 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41787226 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41311233 |
| 56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40301693 |
| 57 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.40008350 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38906003 |
| 59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38448399 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37369372 |
| 61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.36812521 |
| 62 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.36471261 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36422120 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35871514 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35180633 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33080311 |
| 67 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.31998853 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.31573072 |
| 69 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31118211 |
| 70 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30987534 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30987534 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30656366 |
| 73 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.30163370 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28463305 |
| 75 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.26804833 |
| 76 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.25526350 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25203448 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24492777 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24381524 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22105258 |
| 81 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.21481144 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21122434 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20893951 |
| 84 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.20893159 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19929601 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18692368 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18319431 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18087164 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17787442 |
| 90 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16313747 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15804794 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14515869 |
| 93 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14004871 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12949797 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12461654 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12458417 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.12369722 |
| 98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12323499 |
| 99 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12212306 |
| 100 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.11460307 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10375951 |
| 102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10132976 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09531243 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09486904 |
| 105 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09218907 |
| 106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08866702 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08866702 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06706548 |
| 109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05513285 |
| 110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05513285 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05260346 |
| 112 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.05224285 |
| 113 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05112003 |
| 114 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.04854892 |
| 115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04694349 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04287447 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03529326 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03458625 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02228417 |
| 120 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01935945 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01895632 |
| 122 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.01507068 |
| 123 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.01492083 |
| 124 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.01492083 |
| 125 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.01492083 |
| 126 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00798596 |
| 127 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00635118 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99841401 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99424838 |
| 130 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.98886766 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.98139145 |
| 132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98004431 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.97868903 |
| 134 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97291414 |
| 135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96266646 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96266646 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95965891 |
| 138 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95894023 |
| 139 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93392140 |
| 140 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92501356 |
| 141 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91197104 |
| 142 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.90177637 |
| 143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90081796 |
| 144 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.89832204 |
| 145 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.88980064 |
| 146 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.88605463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.76685043 |
| 2 | MP0008004_abnormal_stomach_pH | 3.57299409 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.35905336 |
| 4 | MP0005360_urolithiasis | 3.33114229 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.31851942 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.17831575 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.12644061 |
| 8 | MP0000749_muscle_degeneration | 2.84052080 |
| 9 | MP0006054_spinal_hemorrhage | 2.79525322 |
| 10 | MP0009697_abnormal_copulation | 2.72824186 |
| 11 | MP0003252_abnormal_bile_duct | 2.66947940 |
| 12 | MP0005365_abnormal_bile_salt | 2.58677141 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.46737180 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.34295155 |
| 15 | MP0003315_abnormal_perineum_morphology | 2.33553330 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.28898322 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.26773885 |
| 18 | MP0005076_abnormal_cell_differentiation | 2.05872080 |
| 19 | MP0004233_abnormal_muscle_weight | 2.05271298 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.95222637 |
| 21 | MP0008438_abnormal_cutaneous_collagen | 1.90724741 |
| 22 | MP0003221_abnormal_cardiomyocyte_apopto | 1.82021857 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.80154419 |
| 24 | MP0003941_abnormal_skin_development | 1.78736534 |
| 25 | MP0002269_muscular_atrophy | 1.75677079 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.69333366 |
| 27 | MP0004087_abnormal_muscle_fiber | 1.64836063 |
| 28 | MP0008057_abnormal_DNA_replication | 1.63521820 |
| 29 | MP0009384_cardiac_valve_regurgitation | 1.63311415 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.62611960 |
| 31 | MP0005409_darkened_coat_color | 1.62477123 |
| 32 | MP0000747_muscle_weakness | 1.60649273 |
| 33 | MP0005330_cardiomyopathy | 1.56434307 |
| 34 | MP0001958_emphysema | 1.55114381 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.49524684 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.44000991 |
| 37 | MP0001188_hyperpigmentation | 1.43901023 |
| 38 | MP0000759_abnormal_skeletal_muscle | 1.43753676 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.43654189 |
| 40 | MP0009053_abnormal_anal_canal | 1.42686661 |
| 41 | MP0003385_abnormal_body_wall | 1.42134897 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.40881410 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37603322 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.37571847 |
| 45 | MP0000733_abnormal_muscle_development | 1.37030900 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.35593096 |
| 47 | MP0001666_abnormal_nutrient_absorption | 1.33284744 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.33187498 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.32744290 |
| 50 | MP0003567_abnormal_fetal_cardiomyocyte | 1.32602946 |
| 51 | MP0001849_ear_inflammation | 1.31673181 |
| 52 | MP0000609_abnormal_liver_physiology | 1.30181837 |
| 53 | MP0004130_abnormal_muscle_cell | 1.29450302 |
| 54 | MP0005275_abnormal_skin_tensile | 1.28935311 |
| 55 | MP0004484_altered_response_of | 1.27393748 |
| 56 | MP0002132_abnormal_respiratory_system | 1.26561744 |
| 57 | MP0003115_abnormal_respiratory_system | 1.25255201 |
| 58 | MP0002254_reproductive_system_inflammat | 1.25057659 |
| 59 | MP0001915_intracranial_hemorrhage | 1.24885335 |
| 60 | MP0000751_myopathy | 1.22995307 |
| 61 | MP0010307_abnormal_tumor_latency | 1.21191859 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.18864061 |
| 63 | MP0005620_abnormal_muscle_contractility | 1.18585439 |
| 64 | MP0006138_congestive_heart_failure | 1.16815166 |
| 65 | MP0000537_abnormal_urethra_morphology | 1.15899503 |
| 66 | MP0005248_abnormal_Harderian_gland | 1.15342074 |
| 67 | MP0003091_abnormal_cell_migration | 1.09985602 |
| 68 | MP0004272_abnormal_basement_membrane | 1.09610884 |
| 69 | MP0005408_hypopigmentation | 1.09348972 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.07469384 |
| 71 | MP0001661_extended_life_span | 1.07426768 |
| 72 | MP0005332_abnormal_amino_acid | 1.06643658 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.06326380 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.05348221 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.04592972 |
| 76 | MP0005187_abnormal_penis_morphology | 1.04268508 |
| 77 | MP0002009_preneoplasia | 1.02596240 |
| 78 | MP0005647_abnormal_sex_gland | 1.00817810 |
| 79 | MP0004215_abnormal_myocardial_fiber | 1.00748530 |
| 80 | MP0001299_abnormal_eye_distance/ | 1.00612597 |
| 81 | MP0005023_abnormal_wound_healing | 1.00158713 |
| 82 | MP0003303_peritoneal_inflammation | 0.99147717 |
| 83 | MP0005385_cardiovascular_system_phenoty | 0.98215229 |
| 84 | MP0001544_abnormal_cardiovascular_syste | 0.98215229 |
| 85 | MP0003279_aneurysm | 0.98122627 |
| 86 | MP0002086_abnormal_extraembryonic_tissu | 0.97773009 |
| 87 | MP0004197_abnormal_fetal_growth/weight/ | 0.97179795 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.97093377 |
| 89 | MP0003937_abnormal_limbs/digits/tail_de | 0.95944746 |
| 90 | MP0000428_abnormal_craniofacial_morphol | 0.95647509 |
| 91 | MP0002928_abnormal_bile_duct | 0.95093397 |
| 92 | MP0003868_abnormal_feces_composition | 0.94913485 |
| 93 | MP0010630_abnormal_cardiac_muscle | 0.94393879 |
| 94 | MP0002233_abnormal_nose_morphology | 0.94121363 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.93659580 |
| 96 | MP0000598_abnormal_liver_morphology | 0.92174790 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.92120076 |
| 98 | MP0009278_abnormal_bone_marrow | 0.91063290 |
| 99 | MP0009672_abnormal_birth_weight | 0.89636075 |
| 100 | MP0002796_impaired_skin_barrier | 0.89450611 |
| 101 | MP0002972_abnormal_cardiac_muscle | 0.89239166 |
| 102 | MP0002088_abnormal_embryonic_growth/wei | 0.89134335 |
| 103 | MP0005451_abnormal_body_composition | 0.87679650 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.87575317 |
| 105 | MP0002006_tumorigenesis | 0.86959224 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.86618838 |
| 107 | MP0003984_embryonic_growth_retardation | 0.86364775 |
| 108 | MP0002128_abnormal_blood_circulation | 0.85284354 |
| 109 | MP0009250_abnormal_appendicular_skeleto | 0.85040189 |
| 110 | MP0005621_abnormal_cell_physiology | 0.84871926 |
| 111 | MP0002092_abnormal_eye_morphology | 0.84571717 |
| 112 | MP0002925_abnormal_cardiovascular_devel | 0.83472789 |
| 113 | MP0003935_abnormal_craniofacial_develop | 0.83001365 |
| 114 | MP0002160_abnormal_reproductive_system | 0.81731852 |
| 115 | MP0002118_abnormal_lipid_homeostasis | 0.81572901 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.81506178 |
| 117 | MP0000627_abnormal_mammary_gland | 0.80223348 |
| 118 | MP0002084_abnormal_developmental_patter | 0.79614416 |
| 119 | MP0004947_skin_inflammation | 0.79481130 |
| 120 | MP0009115_abnormal_fat_cell | 0.79254639 |
| 121 | MP0000762_abnormal_tongue_morphology | 0.79218929 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.78491894 |
| 123 | MP0002971_abnormal_brown_adipose | 0.78378876 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.77013531 |
| 125 | MP0009840_abnormal_foam_cell | 0.76678943 |
| 126 | MP0005380_embryogenesis_phenotype | 0.76398379 |
| 127 | MP0001672_abnormal_embryogenesis/_devel | 0.76398379 |
| 128 | MP0005503_abnormal_tendon_morphology | 0.76237158 |
| 129 | MP0001879_abnormal_lymphatic_vessel | 0.76193232 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.75786589 |
| 131 | MP0005499_abnormal_olfactory_system | 0.75786589 |
| 132 | MP0009703_decreased_birth_body | 0.75772103 |
| 133 | MP0000427_abnormal_hair_cycle | 0.75117682 |
| 134 | MP0003950_abnormal_plasma_membrane | 0.74695148 |
| 135 | MP0008007_abnormal_cellular_replicative | 0.74592029 |
| 136 | MP0002168_other_aberrant_phenotype | 0.74438406 |
| 137 | MP0000377_abnormal_hair_follicle | 0.74392593 |
| 138 | MP0005369_muscle_phenotype | 0.73596821 |
| 139 | MP0009780_abnormal_chondrocyte_physiolo | 0.73515060 |
| 140 | MP0003077_abnormal_cell_cycle | 0.73339379 |
| 141 | MP0002133_abnormal_respiratory_system | 0.72023983 |
| 142 | MP0005388_respiratory_system_phenotype | 0.72023983 |
| 143 | MP0003943_abnormal_hepatobiliary_system | 0.71770389 |
| 144 | MP0002115_abnormal_skeleton_extremities | 0.71200539 |
| 145 | MP0000371_diluted_coat_color | 0.71015683 |
| 146 | MP0003755_abnormal_palate_morphology | 0.71005977 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.69854442 |
| 148 | MP0000604_amyloidosis | 0.69599833 |
| 149 | MP0000432_abnormal_head_morphology | 0.69314849 |
| 150 | MP0000266_abnormal_heart_morphology | 0.69096188 |
| 151 | MP0003436_decreased_susceptibility_to | 0.69042061 |
| 152 | MP0000462_abnormal_digestive_system | 0.68538091 |
| 153 | MP0002282_abnormal_trachea_morphology | 0.68078779 |
| 154 | MP0000383_abnormal_hair_follicle | 0.68033981 |
| 155 | MP0001730_embryonic_growth_arrest | 0.67932461 |
| 156 | MP0003828_pulmonary_edema | 0.67445381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the columella (HP:0009929) | 4.48668090 |
| 2 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 4.21733540 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 3.86320935 |
| 4 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.75120566 |
| 5 | Resting tremor (HP:0002322) | 3.74315459 |
| 6 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.71937240 |
| 7 | Rimmed vacuoles (HP:0003805) | 3.54442721 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 3.50222534 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.47035748 |
| 10 | Spinal cord lesions (HP:0100561) | 3.42118172 |
| 11 | Syringomyelia (HP:0003396) | 3.42118172 |
| 12 | Abnormality of the shoulder girdle musculature (HP:0001435) | 3.39865950 |
| 13 | Scapular winging (HP:0003691) | 3.34418588 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.26193142 |
| 15 | Spinal rigidity (HP:0003306) | 3.21844462 |
| 16 | Abnormality of the frontal sinuses (HP:0002687) | 3.13522744 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 3.07506234 |
| 18 | Thoracic kyphosis (HP:0002942) | 3.05827074 |
| 19 | Urinary urgency (HP:0000012) | 3.05149836 |
| 20 | Reduced antithrombin III activity (HP:0001976) | 3.02522180 |
| 21 | Subacute progressive viral hepatitis (HP:0006572) | 2.98326943 |
| 22 | Cerebral aneurysm (HP:0004944) | 2.95233261 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 2.94727974 |
| 24 | Xanthomatosis (HP:0000991) | 2.80314424 |
| 25 | Aortic aneurysm (HP:0004942) | 2.78775729 |
| 26 | Turricephaly (HP:0000262) | 2.76861033 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 2.76215621 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 2.75328853 |
| 29 | Hematochezia (HP:0002573) | 2.74614396 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.68075796 |
| 31 | Mitral valve prolapse (HP:0001634) | 2.61022471 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60312044 |
| 33 | Myocardial infarction (HP:0001658) | 2.58659869 |
| 34 | Shallow orbits (HP:0000586) | 2.58319411 |
| 35 | Curly hair (HP:0002212) | 2.57623067 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.55604113 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 2.55581423 |
| 38 | Clumsiness (HP:0002312) | 2.55070423 |
| 39 | Abnormality of the lumbar spine (HP:0100712) | 2.53449639 |
| 40 | Papillary thyroid carcinoma (HP:0002895) | 2.53336794 |
| 41 | Hypoglycemic coma (HP:0001325) | 2.51440929 |
| 42 | Limb-girdle muscle atrophy (HP:0003797) | 2.51056878 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.50776908 |
| 44 | Thoracolumbar scoliosis (HP:0002944) | 2.47813136 |
| 45 | Osteolytic defects of the hand bones (HP:0009699) | 2.42411273 |
| 46 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42411273 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.41847101 |
| 48 | Complement deficiency (HP:0004431) | 2.38594412 |
| 49 | Capillary hemangiomas (HP:0005306) | 2.38432143 |
| 50 | Macroorchidism (HP:0000053) | 2.38262872 |
| 51 | Pelvic girdle muscle weakness (HP:0003749) | 2.38205096 |
| 52 | Spastic diplegia (HP:0001264) | 2.38118430 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.35772533 |
| 54 | Proximal amyotrophy (HP:0007126) | 2.35563956 |
| 55 | Asymmetry of the thorax (HP:0001555) | 2.35477171 |
| 56 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.35198786 |
| 57 | Short 4th metacarpal (HP:0010044) | 2.35198786 |
| 58 | Neck muscle weakness (HP:0000467) | 2.33716214 |
| 59 | Aneurysm (HP:0002617) | 2.32864778 |
| 60 | Shoulder girdle muscle weakness (HP:0003547) | 2.32360033 |
| 61 | Lymphangioma (HP:0100764) | 2.32002753 |
| 62 | Abnormality of proline metabolism (HP:0010907) | 2.30944333 |
| 63 | Hydroxyprolinuria (HP:0003080) | 2.30944333 |
| 64 | Difficulty running (HP:0009046) | 2.29945352 |
| 65 | Renovascular hypertension (HP:0100817) | 2.29862104 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.29235886 |
| 67 | Abnormality of the common coagulation pathway (HP:0010990) | 2.28902368 |
| 68 | Disinhibition (HP:0000734) | 2.26275426 |
| 69 | Persistence of primary teeth (HP:0006335) | 2.25247850 |
| 70 | Epidermoid cyst (HP:0200040) | 2.23211024 |
| 71 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.21465858 |
| 72 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.21465858 |
| 73 | Elfin facies (HP:0004428) | 2.17757112 |
| 74 | Hypolipoproteinemia (HP:0010981) | 2.17756266 |
| 75 | Calf muscle hypertrophy (HP:0008981) | 2.15761384 |
| 76 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15571773 |
| 77 | Absent frontal sinuses (HP:0002688) | 2.15281659 |
| 78 | Frequent falls (HP:0002359) | 2.14786227 |
| 79 | Aortic dissection (HP:0002647) | 2.14381240 |
| 80 | Hyperacusis (HP:0010780) | 2.14007380 |
| 81 | High anterior hairline (HP:0009890) | 2.13072240 |
| 82 | Muscular dystrophy (HP:0003560) | 2.12425762 |
| 83 | Subaortic stenosis (HP:0001682) | 2.12371686 |
| 84 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.12371686 |
| 85 | Broad metatarsal (HP:0001783) | 2.11916420 |
| 86 | Spondylolisthesis (HP:0003302) | 2.11275417 |
| 87 | Aplasia cutis congenita (HP:0001057) | 2.10592289 |
| 88 | Enlarged penis (HP:0000040) | 2.08742684 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 2.08320619 |
| 90 | Arterial tortuosity (HP:0005116) | 2.08238404 |
| 91 | Back pain (HP:0003418) | 2.06834253 |
| 92 | Abnormality of the 4th metacarpal (HP:0010012) | 2.06138221 |
| 93 | Abnormality of the fingertips (HP:0001211) | 2.05176570 |
| 94 | Muscle fiber splitting (HP:0003555) | 2.04903769 |
| 95 | Termporal pattern (HP:0011008) | 2.04173277 |
| 96 | Insidious onset (HP:0003587) | 2.04173277 |
| 97 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.02270856 |
| 98 | Abnormality of the peritoneum (HP:0002585) | 2.01031309 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 2.00917059 |
| 100 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.00633945 |
| 101 | Vascular tortuosity (HP:0004948) | 2.00449217 |
| 102 | Bladder diverticulum (HP:0000015) | 2.00412787 |
| 103 | Hyperglycemia (HP:0003074) | 2.00218924 |
| 104 | Limb-girdle muscle weakness (HP:0003325) | 2.00201568 |
| 105 | Distal arthrogryposis (HP:0005684) | 1.99823324 |
| 106 | Thin bony cortex (HP:0002753) | 1.99373695 |
| 107 | Steppage gait (HP:0003376) | 1.97693518 |
| 108 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.96962402 |
| 109 | Gastrointestinal carcinoma (HP:0002672) | 1.96962402 |
| 110 | Esophageal varix (HP:0002040) | 1.96538553 |
| 111 | Skin nodule (HP:0200036) | 1.94853375 |
| 112 | Facial hemangioma (HP:0000329) | 1.94357799 |
| 113 | Increased connective tissue (HP:0009025) | 1.94153648 |
| 114 | Hypobetalipoproteinemia (HP:0003563) | 1.93332866 |
| 115 | Ankyloglossia (HP:0010296) | 1.92001507 |
| 116 | Pseudobulbar signs (HP:0002200) | 1.91704477 |
| 117 | Abnormality of complement system (HP:0005339) | 1.91018464 |
| 118 | Abnormal hair whorl (HP:0010721) | 1.90852738 |
| 119 | Mitral stenosis (HP:0001718) | 1.90694672 |
| 120 | Renal duplication (HP:0000075) | 1.90412805 |
| 121 | Ulnar bowing (HP:0003031) | 1.89582503 |
| 122 | Papilledema (HP:0001085) | 1.89461887 |
| 123 | Bowel diverticulosis (HP:0005222) | 1.88092495 |
| 124 | Cortical dysplasia (HP:0002539) | 1.88018924 |
| 125 | Eosinophilia (HP:0001880) | 1.87283663 |
| 126 | Rectal prolapse (HP:0002035) | 1.86768496 |
| 127 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.86122121 |
| 128 | Hypochromic microcytic anemia (HP:0004840) | 1.85107848 |
| 129 | Striae distensae (HP:0001065) | 1.84660205 |
| 130 | Long toe (HP:0010511) | 1.83845566 |
| 131 | Premature rupture of membranes (HP:0001788) | 1.82946367 |
| 132 | Peritonitis (HP:0002586) | 1.82862405 |
| 133 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.82651940 |
| 134 | Abnormality of the diencephalon (HP:0010662) | 1.82602768 |
| 135 | Overriding aorta (HP:0002623) | 1.80029827 |
| 136 | Deviation of the hallux (HP:0010051) | 1.79600156 |
| 137 | Exostoses (HP:0100777) | 1.79528817 |
| 138 | Heterotopia (HP:0002282) | 1.78008807 |
| 139 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.77901943 |
| 140 | Long eyelashes (HP:0000527) | 1.77157147 |
| 141 | Pulmonic stenosis (HP:0001642) | 1.76450373 |
| 142 | Tibial bowing (HP:0002982) | 1.76048927 |
| 143 | Camptodactyly of toe (HP:0001836) | 1.75105346 |
| 144 | Diaphragmatic weakness (HP:0009113) | 1.75059601 |
| 145 | Sudden death (HP:0001699) | 1.74748887 |
| 146 | Relative macrocephaly (HP:0004482) | 1.74714519 |
| 147 | Nemaline bodies (HP:0003798) | 1.74227358 |
| 148 | Bulbar palsy (HP:0001283) | 1.73614488 |
| 149 | Difficulty climbing stairs (HP:0003551) | 1.72466223 |
| 150 | Radial bowing (HP:0002986) | 1.72412344 |
| 151 | Focal segmental glomerulosclerosis (HP:0000097) | 1.72079493 |
| 152 | Hallux valgus (HP:0001822) | 1.71881999 |
| 153 | Ankle contracture (HP:0006466) | 1.70201055 |
| 154 | Abnormality of oral frenula (HP:0000190) | 1.69891233 |
| 155 | Bladder carcinoma (HP:0002862) | 1.68959973 |
| 156 | Bladder neoplasm (HP:0009725) | 1.68959973 |
| 157 | Biliary tract neoplasm (HP:0100574) | 1.68741641 |
| 158 | Sensory axonal neuropathy (HP:0003390) | 1.68107555 |
| 159 | Postural instability (HP:0002172) | 1.67730429 |
| 160 | Knee flexion contracture (HP:0006380) | 1.66717199 |
| 161 | Overgrowth (HP:0001548) | 1.66648216 |
| 162 | Hypoglycemic seizures (HP:0002173) | 1.66530389 |
| 163 | Tetraparesis (HP:0002273) | 1.66309043 |
| 164 | Narrow palate (HP:0000189) | 1.66173215 |
| 165 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.65328413 |
| 166 | Right ventricular cardiomyopathy (HP:0011663) | 1.64558248 |
| 167 | Colitis (HP:0002583) | 1.64397380 |
| 168 | Popliteal pterygium (HP:0009756) | 1.64215887 |
| 169 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.64128133 |
| 170 | Type 1 muscle fiber predominance (HP:0003803) | 1.64016695 |
| 171 | Hyperlipoproteinemia (HP:0010980) | 1.63474182 |
| 172 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.63274789 |
| 173 | Hypoplastic ischia (HP:0003175) | 1.62980019 |
| 174 | Ketosis (HP:0001946) | 1.62248337 |
| 175 | Blue sclerae (HP:0000592) | 1.61743473 |
| 176 | Mitral regurgitation (HP:0001653) | 1.61327807 |
| 177 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.60562834 |
| 178 | Cubitus valgus (HP:0002967) | 1.60124206 |
| 179 | Broad nasal tip (HP:0000455) | 1.59676432 |
| 180 | Myoglobinuria (HP:0002913) | 1.59266204 |
| 181 | Thyroid carcinoma (HP:0002890) | 1.59076551 |
| 182 | Self-mutilation (HP:0000742) | 1.57642595 |
| 183 | Recurrent corneal erosions (HP:0000495) | 1.57263444 |
| 184 | Foot dorsiflexor weakness (HP:0009027) | 1.54601733 |
| 185 | Abnormality of the foot musculature (HP:0001436) | 1.53362819 |
| 186 | Protruding tongue (HP:0010808) | 1.51697144 |
| 187 | Apathy (HP:0000741) | 1.50871084 |
| 188 | Weak cry (HP:0001612) | 1.50264330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 6.54189062 |
| 2 | LATS1 | 4.63152024 |
| 3 | OBSCN | 3.48018554 |
| 4 | PKN2 | 3.04691838 |
| 5 | TRIB3 | 2.82826630 |
| 6 | TTN | 2.53708812 |
| 7 | CDK12 | 2.46531518 |
| 8 | EEF2K | 2.43056949 |
| 9 | CAMK1D | 2.26458544 |
| 10 | FRK | 2.26075046 |
| 11 | SIK1 | 2.22457027 |
| 12 | PTK6 | 2.17805310 |
| 13 | SCYL2 | 2.13324316 |
| 14 | NEK2 | 2.11104139 |
| 15 | ERN1 | 2.03893188 |
| 16 | STK3 | 1.98064487 |
| 17 | EIF2AK3 | 1.95529447 |
| 18 | CDK6 | 1.91358727 |
| 19 | MAP2K7 | 1.89204210 |
| 20 | DYRK3 | 1.87873741 |
| 21 | MYLK | 1.80667498 |
| 22 | PDGFRA | 1.80218303 |
| 23 | RIPK1 | 1.77147690 |
| 24 | MAP3K2 | 1.71305711 |
| 25 | ICK | 1.67513152 |
| 26 | MAP3K10 | 1.67139435 |
| 27 | CAMK1G | 1.65497622 |
| 28 | AKT3 | 1.62796213 |
| 29 | STK10 | 1.59248997 |
| 30 | TAOK3 | 1.56059448 |
| 31 | MAP3K5 | 1.56020337 |
| 32 | FGFR3 | 1.44616545 |
| 33 | SGK2 | 1.42684907 |
| 34 | DMPK | 1.41847096 |
| 35 | MAP2K3 | 1.38637756 |
| 36 | BMX | 1.35517414 |
| 37 | MAP3K1 | 1.34905585 |
| 38 | SGK494 | 1.31391584 |
| 39 | SGK223 | 1.31391584 |
| 40 | FGFR4 | 1.31280862 |
| 41 | PDGFRB | 1.28971357 |
| 42 | MAP3K7 | 1.24840716 |
| 43 | FGFR2 | 1.24442224 |
| 44 | MOS | 1.24422861 |
| 45 | LATS2 | 1.23790573 |
| 46 | NLK | 1.23190374 |
| 47 | FLT3 | 1.22566828 |
| 48 | MTOR | 1.20718390 |
| 49 | MAP3K13 | 1.19894814 |
| 50 | CDK3 | 1.18120385 |
| 51 | PRPF4B | 1.16669852 |
| 52 | TGFBR2 | 1.15547737 |
| 53 | RET | 1.14923927 |
| 54 | LRRK2 | 1.14748347 |
| 55 | NUAK1 | 1.14172487 |
| 56 | KSR2 | 1.13877820 |
| 57 | MAP3K9 | 1.13725882 |
| 58 | ERBB4 | 1.11523643 |
| 59 | RPS6KB1 | 1.11304826 |
| 60 | MAPKAPK3 | 1.06537478 |
| 61 | NEK9 | 1.03786620 |
| 62 | MAP3K6 | 1.03155496 |
| 63 | DDR2 | 1.02362144 |
| 64 | FGFR1 | 1.01884487 |
| 65 | PTK2 | 0.99930403 |
| 66 | IRAK2 | 0.93825749 |
| 67 | EPHB1 | 0.93158779 |
| 68 | CSNK1G3 | 0.92411954 |
| 69 | SRPK1 | 0.92179477 |
| 70 | INSRR | 0.89933238 |
| 71 | MET | 0.88996768 |
| 72 | CSNK1G1 | 0.87018215 |
| 73 | MAP3K8 | 0.84650748 |
| 74 | CDC7 | 0.84251278 |
| 75 | PIK3CG | 0.84134810 |
| 76 | EPHA3 | 0.81032630 |
| 77 | JAK1 | 0.80759754 |
| 78 | CSNK1G2 | 0.80750976 |
| 79 | CDK4 | 0.80535675 |
| 80 | JAK3 | 0.80089182 |
| 81 | RPS6KB2 | 0.78710450 |
| 82 | MELK | 0.75173985 |
| 83 | ACVR1B | 0.74363325 |
| 84 | JAK2 | 0.73418694 |
| 85 | FGR | 0.72090561 |
| 86 | PRKAA2 | 0.69955918 |
| 87 | CSK | 0.69885123 |
| 88 | CDK9 | 0.69628195 |
| 89 | CLK1 | 0.67981186 |
| 90 | MST1R | 0.66640868 |
| 91 | ITK | 0.66588970 |
| 92 | MAP2K4 | 0.65727660 |
| 93 | YES1 | 0.65656281 |
| 94 | EGFR | 0.65414876 |
| 95 | STK38 | 0.62325074 |
| 96 | PAK4 | 0.61710191 |
| 97 | MAP4K1 | 0.60934817 |
| 98 | CHUK | 0.59972921 |
| 99 | PAK2 | 0.59093152 |
| 100 | EPHA2 | 0.58469817 |
| 101 | TRPM7 | 0.58418611 |
| 102 | GSK3A | 0.57705413 |
| 103 | KSR1 | 0.57433829 |
| 104 | TAOK1 | 0.56347678 |
| 105 | ERBB2 | 0.55199020 |
| 106 | CDC42BPA | 0.54628195 |
| 107 | PIK3CA | 0.53867246 |
| 108 | SGK3 | 0.52476743 |
| 109 | TYK2 | 0.52041352 |
| 110 | AKT2 | 0.52037088 |
| 111 | TTK | 0.51825315 |
| 112 | BCR | 0.50237039 |
| 113 | FER | 0.50205204 |
| 114 | MAPK12 | 0.49595949 |
| 115 | DYRK1B | 0.49260541 |
| 116 | ALK | 0.48354448 |
| 117 | BRD4 | 0.48323380 |
| 118 | PRKG2 | 0.47845966 |
| 119 | TBK1 | 0.47035299 |
| 120 | MAP3K3 | 0.46407260 |
| 121 | MKNK1 | 0.46322823 |
| 122 | BRSK2 | 0.45719675 |
| 123 | MAP3K14 | 0.45022915 |
| 124 | CSF1R | 0.43845848 |
| 125 | CSNK1D | 0.43242365 |
| 126 | MAPK11 | 0.42951959 |
| 127 | MARK3 | 0.42840719 |
| 128 | TGFBR1 | 0.42539115 |
| 129 | RPS6KA4 | 0.41968267 |
| 130 | ZAP70 | 0.40191919 |
| 131 | RAF1 | 0.39407169 |
| 132 | RPS6KA1 | 0.39246363 |
| 133 | HIPK2 | 0.39091836 |
| 134 | CDK14 | 0.38432910 |
| 135 | ERBB3 | 0.38041048 |
| 136 | RPS6KA5 | 0.37788070 |
| 137 | IGF1R | 0.37595245 |
| 138 | PAK3 | 0.37588601 |
| 139 | STK4 | 0.37319539 |
| 140 | INSR | 0.37192833 |
| 141 | ABL1 | 0.36618555 |
| 142 | CSNK1A1L | 0.36526308 |
| 143 | STK38L | 0.36039110 |
| 144 | PRKD1 | 0.35241351 |
| 145 | TIE1 | 0.35056400 |
| 146 | PRKAA1 | 0.32757271 |
| 147 | ATM | 0.31295033 |
| 148 | MAPK10 | 0.30951558 |
| 149 | RPS6KA2 | 0.30246279 |
| 150 | MARK2 | 0.28650917 |
| 151 | CAMK4 | 0.25791792 |
| 152 | PRKCQ | 0.25207022 |
| 153 | MAP3K4 | 0.25166852 |
| 154 | MKNK2 | 0.25024244 |
| 155 | BTK | 0.24978341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.21479801 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.65970482 |
| 3 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.56633044 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08571053 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07094259 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01752773 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 2.01408644 |
| 8 | Lysine degradation_Homo sapiens_hsa00310 | 2.01092290 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96306977 |
| 10 | Gap junction_Homo sapiens_hsa04540 | 1.87515368 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83512631 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80263048 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74128456 |
| 14 | Thyroid cancer_Homo sapiens_hsa05216 | 1.71809465 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62849046 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59479004 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53467488 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50477833 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.45223075 |
| 20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.44949003 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39431469 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.38188970 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33771865 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.31253315 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.30795504 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.28368624 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27814990 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26452718 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24655861 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.16690395 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15271407 |
| 32 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.14956820 |
| 33 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.13450801 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.13380564 |
| 35 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13348731 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12682994 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12574151 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12516760 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.12185962 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11801511 |
| 41 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.11402054 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09263756 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 1.06016946 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04567446 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.02797145 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00324827 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99475887 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99349794 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97711348 |
| 50 | Olfactory transduction_Homo sapiens_hsa04740 | 0.97671340 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.97299392 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.94223501 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94011421 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94010420 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93956738 |
| 56 | Melanoma_Homo sapiens_hsa05218 | 0.93379345 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.92849105 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92603561 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.91912973 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91356190 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91116880 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90072565 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89192814 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88679098 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88535040 |
| 66 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.88177615 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87748572 |
| 68 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.87415988 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84350902 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84144618 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83375346 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81084915 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.81030848 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80995724 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80806955 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80706221 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.79663412 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.78999567 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78986506 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.77537652 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77466373 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77277946 |
| 83 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76861207 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76763799 |
| 85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76004224 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75705331 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75638999 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.75229793 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74588765 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74143355 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.73750839 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.73037349 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72775653 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72490571 |
| 95 | Tight junction_Homo sapiens_hsa04530 | 0.72201623 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71772201 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71123864 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70417209 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68385763 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68021090 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67550478 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.65408560 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.64937667 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63434178 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63219259 |
| 106 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63004272 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62858407 |
| 108 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.62829613 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.62777768 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62707381 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62550985 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.62401872 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.62061056 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61374474 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60607808 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59714863 |
| 117 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59334736 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59090576 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58459967 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58096491 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57207909 |
| 122 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57115364 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.56569800 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55849541 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55645149 |
| 126 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55363872 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54022075 |
| 128 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52253809 |
| 129 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51839872 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51108240 |
| 131 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50758586 |
| 132 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50567053 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49718998 |
| 134 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49485957 |
| 135 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48948051 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48192151 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48030065 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47285831 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47143528 |
| 140 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46368954 |
| 141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46228613 |
| 142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45801481 |
| 143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43295542 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43112879 |
| 145 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42956167 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42583370 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41533503 |
| 148 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40858443 |
| 149 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39578963 |

